Pennsylvania could cap prices on medical marijuana

Generic 14 June 2019 | 0 Comments

Are you paying too much for medical marijuana? Millions of Americans are legally replacing pharmaceuticals with cannabis and the question of affordability has become critical. All of the state programs are independent and in various stages of maturity. Prices, even for closely similar products, have a wide range. Confused consumers are often paying $1000 per […]

Tagged in , , ,

FDA Hearing On ‘Hemp-Derived CBD’ Today

Generic 1 June 2019 | 0 Comments

Washington, DC: Today the US Food and Drug Administration is taking in-person public testimony with regard to the “manufacturing, product quality, marketing, labeling, and sale” of CBD-infused retail products. “The rapidly evolving hemp-derived CBD marketplace sadly includes a number of bad faith actors selling the equivalent of modern day snake-oil,” said NORML Political Director Justin Strekal. “With […]

Tagged in , , ,

NORML Submits Comments to FDA Ahead of CBD Hearing

Generic 16 May 2019 | 0 Comments

NORML has submitted written comments to the US Food and Drug Administration ahead of the agency’s scheduled hearing on the regulation CBD-infused products. The agency will be taking in person public testimony on Friday, May 31, with regard to the “manufacturing, product quality, marketing, labeling, and sale” of CBD-infused retail products. In its written testimony, […]

Tagged in , , ,

Study: Marijuana Provided For FDA-Approved Clinical Research Genetically Similar to Hemp

Generic 16 April 2019 | 0 Comments

Marijuana grown by the University of Mississippi for clinical research purposes is genetically divergent from strains of cannabis commercially available in retail markets, according to an analysis prepared by researchers at the University of Northern Colorado. Since 1968, the University of Mississippi farm, which is governed by the US National Institute on Drug Abuse, has […]

Tagged in , , ,

NORML Submits Public Comments To FDA Regarding The International Scheduling Of Marijuana

Generic 15 March 2019 | 0 Comments

The US Food and Drug Administration sought public comments specific to whether changes ought to be recommended regarding imposing international manufacturing and distributing restrictions, under international treaties, on certain drug substances. Per the FDA: FDA, on behalf of the Secretary of HHS, invites interested persons to submit comments on the notifications from the United Nations concerning […]

Tagged in , , ,